Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harvey G Moore

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Diseases of the Colon and Rectum|November 7, 2015
HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy EraDavid Grew, Danielle Bitterman, Cynthia G Leichman, et al.
Diseases of the Colon and Rectum|October 18, 2005
Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a caseRobert Finch, Harvey G Moore, Noralane Lindor, et al.
Frontiers in Oncology|January 7, 2016
Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal CancerDanielle S Bitterman, Lucas Resende Salgado, Harvey G Moore, et al.
World Journal of Surgical Oncology|December 10, 2009
Three synchronous primary carcinomas in a patient with HNPCC associated with a novel germline mutation in MLH1: Case reportCristian D Valenzuela, Harvey G Moore, William C Huang, et al.
Annals of Surgical Oncology|January 7, 2003
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapyHarvey G Moore, Elyn Riedel, Bruce D Minsky, et al.
Annals of Surgery|April 7, 2007
Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical managementJose G Guillem, Emily Glogowski, Harvey G Moore, et al.
Annals of Surgery|January 2, 2007
A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservationJose G Guillem, David B Chessin, Jinru Shia, et al.
Clinical Colorectal Cancer|October 3, 2012
Patients with colorectal and renal cell carcinoma diagnoses appear to be at risk for additional malignanciesEmily Steinhagen, Harvey G Moore, Steven A Lee-Kong, et al.
Familial Cancer|November 2, 2004
A636P testing in Ashkenazi JewsJose G Guillem, Harvey G Moore, Crystal Palmer, et al.
Annals of Surgical Oncology|February 6, 2004
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?Francesco Stipa, Alma Zernecke, Harvey G Moore, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Diseases of the Colon and Rectum|November 7, 2015
HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy EraDavid Grew, Danielle Bitterman, Cynthia G Leichman, et al.
Diseases of the Colon and Rectum|October 18, 2005
Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a caseRobert Finch, Harvey G Moore, Noralane Lindor, et al.
Frontiers in Oncology|January 7, 2016
Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal CancerDanielle S Bitterman, Lucas Resende Salgado, Harvey G Moore, et al.
World Journal of Surgical Oncology|December 10, 2009
Three synchronous primary carcinomas in a patient with HNPCC associated with a novel germline mutation in MLH1: Case reportCristian D Valenzuela, Harvey G Moore, William C Huang, et al.
Annals of Surgical Oncology|January 7, 2003
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapyHarvey G Moore, Elyn Riedel, Bruce D Minsky, et al.
Annals of Surgery|April 7, 2007
Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical managementJose G Guillem, Emily Glogowski, Harvey G Moore, et al.
Annals of Surgery|January 2, 2007
A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservationJose G Guillem, David B Chessin, Jinru Shia, et al.
Clinical Colorectal Cancer|October 3, 2012
Patients with colorectal and renal cell carcinoma diagnoses appear to be at risk for additional malignanciesEmily Steinhagen, Harvey G Moore, Steven A Lee-Kong, et al.
Familial Cancer|November 2, 2004
A636P testing in Ashkenazi JewsJose G Guillem, Harvey G Moore, Crystal Palmer, et al.
Annals of Surgical Oncology|February 6, 2004
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?Francesco Stipa, Alma Zernecke, Harvey G Moore, et al.
Pageof 3